๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Alterations in plasma sialyltransferase levels in patients with neoplastic disease

โœ Scribed by Michael Henderson; David Kessel


Publisher
John Wiley and Sons
Year
1977
Tongue
English
Weight
460 KB
Volume
39
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

โœฆ Synopsis


Levels of g1ycoprotein:sialyltransferase activity (EC 2.4.99.1 ; CMP-acetylneuraminate:D-galactosyl-glycoprotein N-acetylneuraminyl-transferase) were measured in plasma of patients with neoplastic disease, and were found elevated above normal control values in 85% of patients examined. There was a correlation between enzyme levels and course of disease in 46 of 57 patients studied serially during therapy. Plasma sialyltransferase may be a useful marker enzyme for monitoring effectiveness of therapeutic programs for disseminated neoplasms.


๐Ÿ“œ SIMILAR VOLUMES


Plasma prostaglandins in hypercalcemic p
โœ L. M. Demers; J. C. Allegra; H. A. Harvey; A. Lipton; J. R. Luderer; R. Mortel; ๐Ÿ“‚ Article ๐Ÿ“… 1977 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 337 KB

Peripheral plasma prostaglandin E (PGE) determinations were performed on a series of 79 patients with solid tumor neoplasms and correlated with their serum calcium levels. Fourteen patients were hypercalcemic and 11 of these had significant elevations in circulating plasma PGE. Ten of the hypercalce

Plasma thrombospondin levels in patients
โœ Yuichi Yamashita; Toshihiko Kurohiji; George P. Tuszynski; Toshimi Sakai; Takayu ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 87 KB ๐Ÿ‘ 2 views

as a secretion product of thrombin-stimulated platelets. In a recent study, throm-